These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 23094609)
1. Effect of antioxidants on the stability of ONO-1301, a novel long-acting prostacyclin agonist, loaded in PLGA microspheres. Uchida T; Hazekawa M; Morisaki T; Yoshida M; Sakai Y J Microencapsul; 2013; 30(3):245-56. PubMed ID: 23094609 [TBL] [Abstract][Full Text] [Related]
2. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model. Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583 [TBL] [Abstract][Full Text] [Related]
3. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
4. The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T J Microencapsul; 2012; 29(3):211-8. PubMed ID: 22360765 [TBL] [Abstract][Full Text] [Related]
5. Single injection of ONO-1301-loaded PLGA microspheres directly after ischaemia reduces ischaemic damage in rats subjected to middle cerebral artery occlusion. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T J Pharm Pharmacol; 2012 Mar; 64(3):353-9. PubMed ID: 22309267 [TBL] [Abstract][Full Text] [Related]
6. Effect of Self-healing Encapsulation on the Initial Burst Release from PLGA Microspheres Containing a Long-Acting Prostacyclin Agonist, ONO-1301. Hazekawa M; Kojima H; Haraguchi T; Yoshida M; Uchida T Chem Pharm Bull (Tokyo); 2017; 65(7):653-659. PubMed ID: 28674339 [TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474 [TBL] [Abstract][Full Text] [Related]
8. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions. Murty SB; Goodman J; Thanoo BC; DeLuca PP AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Chu DF; Fu XQ; Liu WH; Liu K; Li YX Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971 [TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
11. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related]
12. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
13. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969 [TBL] [Abstract][Full Text] [Related]
14. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
15. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres. Kim H; Jeong D; Kang HE; Lee KC; Na K J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683 [TBL] [Abstract][Full Text] [Related]
16. Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres. Tomoda K; Kojima S; Kajimoto M; Watanabe D; Nakajima T; Makino K Colloids Surf B Biointerfaces; 2005 Sep; 45(1):1-6. PubMed ID: 16099143 [TBL] [Abstract][Full Text] [Related]
17. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist. Okamoto T; Uemoto S; Tabata Y J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734 [TBL] [Abstract][Full Text] [Related]
18. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Chaisri W; Ghassemi AH; Hennink WE; Okonogi S Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499 [TBL] [Abstract][Full Text] [Related]
20. Preparation and in vivo evaluation of PCADK/PLGA microspheres for improving stability and efficacy of rhGH. Wang C; Yu C; Liu J; Teng L; Sun F; Li Y Int J Pharm; 2015 Nov; 495(2):924-31. PubMed ID: 26456269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]